Jubilant HollisterStier Secures Sterile Parenteral Manufacturing Contracts
Spokane, WA, U.S.A., November 13, 2012 Jubilant HollisterStier, a subsidiary of Jubilant Life Sciences, announced today that its Contract Manufacturing & Services division has recently secured over $100M USD contracts with leading pharmaceutical companies for the commercial manufacturing of multiple sterile parenteral products. These awards are the continuation of existing relationships and will be executed across both parenteral manufacturing locations in Spokane WA, and Montreal Canada. The commercial technology transfer efforts are expected to commence in 2013.
"We are excited to expand our existing strategic commercial relationships, and will bring forward our capabilities in manufacturing excellence, rigorous quality oversight and project management to support a smooth and timely transfer to our manufacturing locations, said Jubilant HollisterStier Chief Executive Officer, Marcelo Morales.
About Jubilant HollisterStier Contract Manufacturing & Services Division
Jubilant HollisterStier Contract Manufacturing & Services Division is a subsidiary of Jubilant Life Sciences, an integrated pharma and life sciences company headquartered in India. Jubilant HollisterStier provides its customers manufacturing services to aseptically fill liquid and lyophilized products, semi-solid and solid dosage forms at its facilities in the United States, Canada, and India. Jubilant HollisterStier offers highly-skilled, cross-functional teams to provide custom solutions to customer-specific project goals from development through commercialization. Jubilant HollisterStier is committed to providing exceptional quality, regulatory expertise and operational excellence to ensure streamlined processes and services in all facilities. For more info about Jubilant HollisterStier, visit
About Jubilant Life Sciences
Jubilant Life Sciences Limited is a global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Generics, Specialty Pharmaceuticals and Life Science Ingredients. It also provides Services in Contract Manufacturing and Drug Discovery and Development. The Company’s strength lies in its unique offerings of Pharmaceutical and Life Sciences products and services across the value chain. With 10 world-class manufacturing facilities in India, US and Canada and a team of almost 6400 multicultural people across the globe, the Company is committed to deliver value to its customers spread across over 90 countries. The Company is well recognized as a ‘Partner of Choice’ by leading pharmaceuticals and life sciences companies globally. For more info: www.jubl.com
Shannon Jordan, 509.482.4958